PEDF peptides promote photoreceptor survival in rd10 retina models

Exp Eye Res. 2019 Jul:184:24-29. doi: 10.1016/j.exer.2019.04.008. Epub 2019 Apr 10.

Abstract

The purpose of the study is to evaluate the protective properties of PEDF peptide fragments on rd10 mouse models of retinal degeneration ex vivo. Human recombinant PEDF and synthetic peptides were used. Rd10 retinal explants as well as wild-type retinal explants treated with zaprinast to mimic the rd10 photoreceptor cell death were employed. PEDF protein was intravitreally administered into rd10 mice. Outer nuclear layer thickness measurements in retinal sections, TUNEL labeling in retinal explants, western blots and immunofluorescence with retinal samples were performed. PEDF protein levels in the RPE of rd10 mice decreased with age (P15 - P25). Levels of PEDF receptor PEDF-R declined in the photoreceptor inner segments from rd10 relative to wild-type mice at P25. PEDF administration increased the outer nuclear layer thickness of rd10 retinas in vivo and decreased the number of TUNEL+ nuclei of photoreceptors in rd10 retinal explant cultures, both relative to untreated controls. Peptides containing the PEDF neurotrophic region decreased the number of TUNEL+ photoreceptors in both rd10 and zaprinast-induced cell death ex vivo models, while peptides without the neurotrophic region and/or lacking affinity for PEDF-R were ineffective in protecting photoreceptors. Thus, retinal explants are a valuable system to evaluate PEDF activity. Short peptides with the photoreceptor-protective property of PEDF may prove useful for the development of therapeutic agents for photoreceptor protection in retinal degenerations.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Survival
  • Disease Models, Animal
  • Eye Proteins / therapeutic use*
  • Fluorescent Antibody Technique, Indirect
  • In Situ Nick-End Labeling
  • Intravitreal Injections
  • Mice
  • Mice, Inbred C57BL
  • Nerve Growth Factors / therapeutic use*
  • Peptide Fragments / therapeutic use*
  • Photoreceptor Cells, Vertebrate / drug effects*
  • Photoreceptor Cells, Vertebrate / metabolism
  • Photoreceptor Cells, Vertebrate / pathology
  • Recombinant Proteins
  • Retinal Degeneration / drug therapy*
  • Retinal Degeneration / metabolism
  • Retinal Degeneration / pathology
  • Serpins / therapeutic use*

Substances

  • Eye Proteins
  • Nerve Growth Factors
  • Peptide Fragments
  • Recombinant Proteins
  • Serpins
  • pigment epithelium-derived factor